1. Home
  2. BGSF vs ICCC Comparison

BGSF vs ICCC Comparison

Compare BGSF & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGSF Inc.

BGSF

BGSF Inc.

HOLD

Current Price

$6.07

Market Cap

63.4M

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$6.08

Market Cap

55.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGSF
ICCC
Founded
2007
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.4M
55.5M
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
BGSF
ICCC
Price
$6.07
$6.08
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
24.1K
11.6K
Earning Date
03-11-2026
03-04-2026
Dividend Yield
32.36%
N/A
EPS Growth
67.37
65.33
EPS
N/A
0.20
Revenue
$272,499,000.00
$26,493,169.00
Revenue This Year
$4.67
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$30.20
Revenue Growth
N/A
51.64
52 Week Low
$2.91
$4.52
52 Week High
$8.20
$7.60

Technical Indicators

Market Signals
Indicator
BGSF
ICCC
Relative Strength Index (RSI) 54.39 42.41
Support Level $5.93 $6.13
Resistance Level $6.38 $6.85
Average True Range (ATR) 0.26 0.23
MACD -0.03 -0.06
Stochastic Oscillator 39.77 20.00

Price Performance

Historical Comparison
BGSF
ICCC

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: